WallStSmart

Logitech International SA (LOGI)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Logitech International SA generates 1741% more annual revenue ($4.77B vs $258.90M). LOGI leads profitability with a 14.9% profit margin vs -15.5%. LOGI earns a higher WallStSmart Score of 67/100 (B-).

LOGI

Strong Buy

67

out of 100

Grade: B-

Growth: 5.3Profit: 8.0Value: 7.3Quality: 8.5
Piotroski: 5/9Altman Z: 4.76

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

LOGIUndervalued (+38.0%)

Margin of Safety

+38.0%

Fair Value

$150.52

Current Price

$99.28

$51.24 discount

UndervaluedFair: $150.52Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

LOGI5 strengths · Avg: 9.2/10
Return on EquityProfitability
32.1%10/10

Every $100 of equity generates 32 in profit

Debt/EquityHealth
0.0410/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
4.7610/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
20.2%8/10

Strong operational efficiency at 20.2%

EPS GrowthGrowth
28.0%8/10

Earnings expanding 28.0% YoY

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

LOGI0 concerns · Avg: 0/10

No major concerns identified

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : LOGI

The strongest argument for LOGI centers on Return on Equity, Debt/Equity, Altman Z-Score. PEG of 1.33 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : LOGI

No major red flags identified for LOGI, but monitor valuation.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

LOGI profiles as a value stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor COMPUTER HARDWARE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

LOGI scores higher overall (67/100 vs 41/100). ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Logitech International SA

TECHNOLOGY · COMPUTER HARDWARE · USA

Logitech International SA designs, manufactures and markets products that help people connect to digital and cloud experiences globally. The company is headquartered in Lausanne, Switzerland.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?